Novel motif:27
From FANTOM5_SSTAR
name: | motif27_CCTGCA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0043462 | regulation of ATPase activity | 2.348151e-14 |
GO:0045321 | leukocyte activation | 5.380176e-12 |
GO:0042110 | T cell activation | 3.696196e-11 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.554332e-10 |
GO:0072376 | protein activation cascade | 2.592249e-10 |
GO:0007522 | visceral muscle development | 1.718101e-9 |
GO:0050728 | negative regulation of inflammatory response | 3.011636e-9 |
GO:0046655 | folic acid metabolic process | 5.082912e-9 |
GO:0045104 | intermediate filament cytoskeleton organization | 5.464915e-9 |
GO:0046649 | lymphocyte activation | 6.234167e-9 |
GO:0002679 | respiratory burst involved in defense response | 7.546112e-9 |
GO:0034762 | regulation of transmembrane transport | 8.432219e-9 |
GO:0006956 | complement activation | 8.626217e-9 |
GO:0006545 | glycine biosynthetic process | 1.010643e-8 |
GO:0051917 | regulation of fibrinolysis | 1.213215e-8 |
GO:0045103 | intermediate filament-based process | 1.289789e-8 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 1.319782e-8 |
GO:0050832 | defense response to fungus | 1.565295e-8 |
GO:0006544 | glycine metabolic process | 1.848921e-8 |
GO:0003009 | skeletal muscle contraction | 2.331589e-8 |
GO:0061041 | regulation of wound healing | 2.368799e-8 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 2.422962e-8 |
GO:0046724 | oxalic acid secretion | 3.086503e-8 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 3.086503e-8 |
GO:0044258 | intestinal lipid catabolic process | 3.355298e-8 |
GO:0018350 | protein esterification | 3.355298e-8 |
GO:0002577 | regulation of antigen processing and presentation | 3.609898e-8 |
GO:0032796 | uropod organization | 4.145491e-8 |
GO:0060037 | pharyngeal system development | 4.234614e-8 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 4.322717e-8 |
GO:0006692 | prostanoid metabolic process | 4.384617e-8 |
GO:0009620 | response to fungus | 4.862952e-8 |
GO:0032715 | negative regulation of interleukin-6 production | 4.936645e-8 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 6.392083e-8 |
GO:0090130 | tissue migration | 6.401878e-8 |
GO:0050821 | protein stabilization | 6.680658e-8 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 7.101046e-8 |
GO:0006958 | complement activation, classical pathway | 7.148450e-8 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 8.124191e-8 |
GO:0051918 | negative regulation of fibrinolysis | 9.505968e-8 |
GO:0044130 | negative regulation of growth of symbiont in host | 9.869380e-8 |
GO:0001775 | cell activation | 9.973316e-8 |
GO:0016601 | Rac protein signal transduction | 1.103026e-7 |
GO:0019724 | B cell mediated immunity | 1.242077e-7 |
GO:0006979 | response to oxidative stress | 1.270688e-7 |
GO:0050678 | regulation of epithelial cell proliferation | 1.404229e-7 |
GO:0032101 | regulation of response to external stimulus | 1.623842e-7 |
GO:0043249 | erythrocyte maturation | 1.627562e-7 |
GO:0042415 | norepinephrine metabolic process | 1.727854e-7 |
GO:0043901 | negative regulation of multi-organism process | 1.997708e-7 |
GO:0051234 | establishment of localization | 2.091928e-7 |
GO:0006760 | folic acid-containing compound metabolic process | 2.131472e-7 |
GO:0006952 | defense response | 2.484845e-7 |
GO:0002902 | regulation of B cell apoptosis | 2.491094e-7 |
GO:0060300 | regulation of cytokine activity | 2.671416e-7 |
GO:0031348 | negative regulation of defense response | 3.104723e-7 |
GO:0003229 | ventricular cardiac muscle tissue development | 3.649890e-7 |
GO:0070301 | cellular response to hydrogen peroxide | 3.806347e-7 |
GO:0008016 | regulation of heart contraction | 3.923026e-7 |
GO:0051764 | actin crosslink formation | 4.513450e-7 |
GO:0030193 | regulation of blood coagulation | 4.539607e-7 |
GO:0043368 | positive T cell selection | 4.864470e-7 |
GO:0006811 | ion transport | 5.124739e-7 |
GO:0006909 | phagocytosis | 5.499731e-7 |
GO:0008203 | cholesterol metabolic process | 5.651054e-7 |
GO:0006548 | histidine catabolic process | 5.671186e-7 |
GO:0000212 | meiotic spindle organization | 5.760825e-7 |
GO:0002443 | leukocyte mediated immunity | 5.766906e-7 |
GO:0006810 | transport | 5.874189e-7 |
GO:0022406 | membrane docking | 6.003020e-7 |
GO:0030100 | regulation of endocytosis | 6.702512e-7 |
GO:0046456 | icosanoid biosynthetic process | 7.472407e-7 |
GO:0001836 | release of cytochrome c from mitochondria | 7.992603e-7 |
GO:0016125 | sterol metabolic process | 8.269985e-7 |
GO:0090344 | negative regulation of cell aging | 8.830393e-7 |
GO:0006707 | cholesterol catabolic process | 9.082481e-7 |
GO:0034765 | regulation of ion transmembrane transport | 9.625839e-7 |
GO:0006959 | humoral immune response | 1.014608e-6 |
GO:0035814 | negative regulation of renal sodium excretion | 1.039104e-6 |
GO:0002449 | lymphocyte mediated immunity | 1.132037e-6 |
GO:0051693 | actin filament capping | 1.143434e-6 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1.202169e-6 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 1.271461e-6 |
GO:0016064 | immunoglobulin mediated immune response | 1.282778e-6 |
GO:0002026 | regulation of the force of heart contraction | 1.338066e-6 |
GO:0006821 | chloride transport | 1.349103e-6 |
GO:0060301 | positive regulation of cytokine activity | 1.368107e-6 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 1.389013e-6 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.488755e-6 |
GO:0008078 | mesodermal cell migration | 1.500420e-6 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 1.537155e-6 |
GO:0000302 | response to reactive oxygen species | 1.589957e-6 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 1.616321e-6 |
GO:0002252 | immune effector process | 1.828074e-6 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 1.830421e-6 |
GO:0003180 | aortic valve morphogenesis | 1.984101e-6 |
GO:0050727 | regulation of inflammatory response | 2.056830e-6 |
GO:0003208 | cardiac ventricle morphogenesis | 2.211181e-6 |
GO:0035089 | establishment of apical/basal cell polarity | 2.315840e-6 |
GO:0031295 | T cell costimulation | 2.384773e-6 |
GO:0033326 | cerebrospinal fluid secretion | 2.514954e-6 |
GO:0043269 | regulation of ion transport | 2.653537e-6 |
GO:0015874 | norepinephrine transport | 2.692711e-6 |
GO:0072268 | pattern specification involved in metanephros development | 3.018391e-6 |
GO:0032680 | regulation of tumor necrosis factor production | 3.196382e-6 |
GO:0034220 | ion transmembrane transport | 3.204755e-6 |
GO:0001546 | preantral ovarian follicle growth | 3.478487e-6 |
GO:0051932 | synaptic transmission, GABAergic | 3.478487e-6 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.556583e-6 |
GO:0048144 | fibroblast proliferation | 3.790125e-6 |
GO:0001880 | Mullerian duct regression | 3.790125e-6 |
GO:0045575 | basophil activation | 3.996195e-6 |
GO:0021570 | rhombomere 4 development | 3.996195e-6 |
GO:0001694 | histamine biosynthetic process | 3.996195e-6 |
GO:0006955 | immune response | 4.410768e-6 |
GO:0030195 | negative regulation of blood coagulation | 4.466518e-6 |
GO:0032695 | negative regulation of interleukin-12 production | 4.496802e-6 |
GO:0051298 | centrosome duplication | 5.041468e-6 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 5.239612e-6 |
GO:0001937 | negative regulation of endothelial cell proliferation | 5.325197e-6 |
GO:0051346 | negative regulation of hydrolase activity | 5.562885e-6 |
GO:0030835 | negative regulation of actin filament depolymerization | 5.817582e-6 |
GO:0051179 | localization | 6.214374e-6 |
GO:0002093 | auditory receptor cell morphogenesis | 6.812802e-6 |
GO:0021526 | medial motor column neuron differentiation | 7.373481e-6 |
GO:0051488 | activation of anaphase-promoting complex activity | 7.642860e-6 |
GO:0071392 | cellular response to estradiol stimulus | 8.261592e-6 |
GO:0032720 | negative regulation of tumor necrosis factor production | 9.817000e-6 |
GO:0006633 | fatty acid biosynthetic process | 9.942355e-6 |
GO:0030157 | pancreatic juice secretion | 1.039862e-5 |
GO:0051220 | cytoplasmic sequestering of protein | 1.045504e-5 |
GO:0007155 | cell adhesion | 1.055189e-5 |
GO:0048243 | norepinephrine secretion | 1.081050e-5 |
GO:0006690 | icosanoid metabolic process | 1.106853e-5 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.107043e-5 |
GO:0010535 | positive regulation of activation of JAK2 kinase activity | 1.138110e-5 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 1.149971e-5 |
GO:0071805 | potassium ion transmembrane transport | 1.157863e-5 |
GO:0002903 | negative regulation of B cell apoptosis | 1.182564e-5 |
GO:0072593 | reactive oxygen species metabolic process | 1.192226e-5 |
GO:0050881 | musculoskeletal movement | 1.221583e-5 |
GO:0048278 | vesicle docking | 1.234087e-5 |
GO:0051293 | establishment of spindle localization | 1.251794e-5 |
GO:0000060 | protein import into nucleus, translocation | 1.253556e-5 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 1.354286e-5 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 1.376787e-5 |
GO:0002367 | cytokine production involved in immune response | 1.419145e-5 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 1.461640e-5 |
GO:0045058 | T cell selection | 1.462262e-5 |
GO:0045668 | negative regulation of osteoblast differentiation | 1.513870e-5 |
GO:0042363 | fat-soluble vitamin catabolic process | 1.616253e-5 |
GO:0042744 | hydrogen peroxide catabolic process | 1.618413e-5 |
GO:0055085 | transmembrane transport | 1.637212e-5 |
GO:0002250 | adaptive immune response | 1.738820e-5 |
GO:0007586 | digestion | 1.763606e-5 |
GO:0019226 | transmission of nerve impulse | 1.801895e-5 |
GO:0071636 | positive regulation of transforming growth factor beta production | 1.901329e-5 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.901798e-5 |
GO:0016056 | rhodopsin mediated signaling pathway | 1.905930e-5 |
GO:0070727 | cellular macromolecule localization | 1.946829e-5 |
GO:0044057 | regulation of system process | 1.969223e-5 |
GO:0033559 | unsaturated fatty acid metabolic process | 2.083302e-5 |
GO:0032102 | negative regulation of response to external stimulus | 2.091959e-5 |
GO:0021548 | pons development | 2.101655e-5 |
GO:0009070 | serine family amino acid biosynthetic process | 2.105341e-5 |
GO:0007386 | compartment pattern specification | 2.122464e-5 |
GO:0002019 | regulation of renal output by angiotensin | 2.172671e-5 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 2.174169e-5 |
GO:0043652 | engulfment of apoptotic cell | 2.174169e-5 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 2.174169e-5 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 2.174169e-5 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.174169e-5 |
GO:0045059 | positive thymic T cell selection | 2.207231e-5 |
GO:0051323 | metaphase | 2.318454e-5 |
GO:0032972 | regulation of muscle filament sliding speed | 2.321737e-5 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 2.350614e-5 |
GO:0042491 | auditory receptor cell differentiation | 2.460248e-5 |
GO:0060337 | type I interferon-mediated signaling pathway | 2.547120e-5 |
GO:0009720 | detection of hormone stimulus | 2.548596e-5 |
GO:0034436 | glycoprotein transport | 2.548596e-5 |
GO:0031333 | negative regulation of protein complex assembly | 2.636210e-5 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 2.639797e-5 |
GO:0043206 | fibril organization | 2.747916e-5 |
GO:0043587 | tongue morphogenesis | 2.821062e-5 |
GO:0006434 | seryl-tRNA aminoacylation | 2.917567e-5 |
GO:0050818 | regulation of coagulation | 2.954754e-5 |
GO:0034613 | cellular protein localization | 2.987281e-5 |
GO:0048562 | embryonic organ morphogenesis | 3.047563e-5 |
GO:0032206 | positive regulation of telomere maintenance | 3.080126e-5 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 3.170363e-5 |
GO:0060956 | endocardial cell differentiation | 3.191138e-5 |
GO:0045061 | thymic T cell selection | 3.204940e-5 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 3.211161e-5 |
GO:0034340 | response to type I interferon | 3.259187e-5 |
GO:0009150 | purine ribonucleotide metabolic process | 3.332703e-5 |
GO:0051895 | negative regulation of focal adhesion assembly | 3.336399e-5 |
GO:0002906 | negative regulation of mature B cell apoptosis | 3.388155e-5 |
GO:0031647 | regulation of protein stability | 3.417303e-5 |
GO:0006886 | intracellular protein transport | 3.511948e-5 |
GO:0009141 | nucleoside triphosphate metabolic process | 3.708616e-5 |
GO:0050680 | negative regulation of epithelial cell proliferation | 3.745618e-5 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 3.763506e-5 |
GO:0035264 | multicellular organism growth | 3.767037e-5 |
GO:0051295 | establishment of meiotic spindle localization | 3.789281e-5 |
GO:0072081 | specification of nephron tubule identity | 3.873390e-5 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 3.884140e-5 |
GO:0043585 | nose morphogenesis | 3.895256e-5 |
GO:0007440 | foregut morphogenesis | 4.444854e-5 |
GO:0032707 | negative regulation of interleukin-23 production | 4.561685e-5 |
GO:0046632 | alpha-beta T cell differentiation | 4.781555e-5 |
GO:0048259 | regulation of receptor-mediated endocytosis | 4.819440e-5 |
GO:0009259 | ribonucleotide metabolic process | 4.832910e-5 |
GO:0002376 | immune system process | 4.857273e-5 |
GO:0007632 | visual behavior | 4.981084e-5 |
GO:0007321 | sperm displacement | 5.115382e-5 |
GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | 5.282613e-5 |
GO:0015698 | inorganic anion transport | 5.473595e-5 |
GO:0010757 | negative regulation of plasminogen activation | 5.499756e-5 |
GO:0007423 | sensory organ development | 5.544563e-5 |
GO:0001768 | establishment of T cell polarity | 5.652989e-5 |
GO:0050819 | negative regulation of coagulation | 5.684404e-5 |
GO:0001692 | histamine metabolic process | 5.847895e-5 |
GO:0070585 | protein localization in mitochondrion | 6.073308e-5 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 6.129012e-5 |
GO:0097118 | neuroligin clustering | 6.236890e-5 |
GO:0001970 | positive regulation of activation of membrane attack complex | 6.236890e-5 |
GO:0031639 | plasminogen activation | 6.326237e-5 |
GO:0010872 | regulation of cholesterol esterification | 6.516922e-5 |
GO:0030194 | positive regulation of blood coagulation | 6.598991e-5 |
GO:0090231 | regulation of spindle checkpoint | 6.648404e-5 |
GO:0072659 | protein localization in plasma membrane | 6.673101e-5 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 6.840379e-5 |
GO:0010984 | regulation of lipoprotein particle clearance | 6.870198e-5 |
GO:0051291 | protein heterooligomerization | 7.014501e-5 |
GO:0043535 | regulation of blood vessel endothelial cell migration | 7.102654e-5 |
GO:0006547 | histidine metabolic process | 7.185183e-5 |
GO:0060311 | negative regulation of elastin catabolic process | 7.218906e-5 |
GO:0060313 | negative regulation of blood vessel remodeling | 7.218906e-5 |
GO:0010711 | negative regulation of collagen catabolic process | 7.218906e-5 |
GO:0010703 | negative regulation of histolysis | 7.218906e-5 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 7.339625e-5 |
GO:0010755 | regulation of plasminogen activation | 7.558398e-5 |
GO:0010758 | regulation of macrophage chemotaxis | 7.643111e-5 |
GO:0030198 | extracellular matrix organization | 7.670278e-5 |
GO:0090136 | epithelial cell-cell adhesion | 7.876015e-5 |
GO:0007509 | mesoderm migration involved in gastrulation | 8.144397e-5 |
GO:0070228 | regulation of lymphocyte apoptosis | 8.237191e-5 |
GO:0046034 | ATP metabolic process | 8.459288e-5 |
GO:0010812 | negative regulation of cell-substrate adhesion | 8.673684e-5 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 8.699551e-5 |
GO:0071622 | regulation of granulocyte chemotaxis | 8.734361e-5 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 8.783343e-5 |
GO:0010759 | positive regulation of macrophage chemotaxis | 8.786490e-5 |
GO:0032908 | regulation of transforming growth factor beta1 production | 8.800523e-5 |
GO:0072657 | protein localization in membrane | 8.910968e-5 |
GO:0050866 | negative regulation of cell activation | 9.048809e-5 |
GO:0042421 | norepinephrine biosynthetic process | 9.181280e-5 |
GO:0006706 | steroid catabolic process | 9.216354e-5 |
GO:0060088 | auditory receptor cell stereocilium organization | 9.297154e-5 |
GO:0070613 | regulation of protein processing | 9.826573e-5 |
GO:0034465 | response to carbon monoxide | 9.975502e-5 |
GO:0008625 | induction of apoptosis via death domain receptors | 1.005194e-4 |
GO:0045198 | establishment of epithelial cell apical/basal polarity | 1.014288e-4 |
GO:0006939 | smooth muscle contraction | 1.036975e-4 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 1.040916e-4 |
GO:0030217 | T cell differentiation | 1.068646e-4 |
GO:0001867 | complement activation, lectin pathway | 1.071990e-4 |
GO:0085029 | extracellular matrix assembly | 1.085195e-4 |
GO:0048168 | regulation of neuronal synaptic plasticity | 1.089896e-4 |
GO:0031960 | response to corticosteroid stimulus | 1.107469e-4 |
GO:0072143 | mesangial cell development | 1.126271e-4 |
GO:0045777 | positive regulation of blood pressure | 1.146110e-4 |
GO:0030834 | regulation of actin filament depolymerization | 1.150645e-4 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 1.162597e-4 |
GO:0000185 | activation of MAPKKK activity | 1.179282e-4 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 1.181932e-4 |
GO:0003206 | cardiac chamber morphogenesis | 1.185084e-4 |
GO:0050779 | RNA destabilization | 1.192131e-4 |
GO:0048771 | tissue remodeling | 1.194804e-4 |
GO:0010594 | regulation of endothelial cell migration | 1.242872e-4 |
GO:0006766 | vitamin metabolic process | 1.254183e-4 |
GO:0045112 | integrin biosynthetic process | 1.255559e-4 |
GO:0007051 | spindle organization | 1.262662e-4 |
GO:0051937 | catecholamine transport | 1.313124e-4 |
GO:0030029 | actin filament-based process | 1.326035e-4 |
GO:0060119 | inner ear receptor cell development | 1.338950e-4 |
GO:0002115 | store-operated calcium entry | 1.362524e-4 |
GO:0006801 | superoxide metabolic process | 1.382352e-4 |
GO:0008633 | activation of pro-apoptotic gene products | 1.416077e-4 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 1.418649e-4 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 1.422202e-4 |
GO:0009303 | rRNA transcription | 1.464443e-4 |
GO:0006904 | vesicle docking involved in exocytosis | 1.471544e-4 |
GO:0042098 | T cell proliferation | 1.479205e-4 |
GO:0071356 | cellular response to tumor necrosis factor | 1.497189e-4 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 1.517587e-4 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 1.562174e-4 |
GO:0021984 | adenohypophysis development | 1.624168e-4 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 1.629733e-4 |
GO:0048659 | smooth muscle cell proliferation | 1.646353e-4 |
GO:0007506 | gonadal mesoderm development | 1.646353e-4 |
GO:0048251 | elastic fiber assembly | 1.680560e-4 |
GO:0042743 | hydrogen peroxide metabolic process | 1.685156e-4 |
GO:0019532 | oxalate transport | 1.733252e-4 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.769197e-4 |
GO:0050710 | negative regulation of cytokine secretion | 1.769272e-4 |
GO:0061143 | alveolar primary septum development | 1.810942e-4 |
GO:0035845 | photoreceptor cell outer segment organization | 1.811525e-4 |
GO:0050951 | sensory perception of temperature stimulus | 1.836405e-4 |
GO:0010466 | negative regulation of peptidase activity | 1.848748e-4 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 1.869945e-4 |
GO:0007132 | meiotic metaphase I | 1.895347e-4 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1.897663e-4 |
GO:0072655 | establishment of protein localization in mitochondrion | 1.900032e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 1.916300e-4 |
GO:0061157 | mRNA destabilization | 1.916300e-4 |
GO:0008628 | induction of apoptosis by hormones | 1.973944e-4 |
GO:0003161 | cardiac conduction system development | 1.976427e-4 |
GO:0006626 | protein targeting to mitochondrion | 2.023646e-4 |
GO:0009143 | nucleoside triphosphate catabolic process | 2.068446e-4 |
GO:0010810 | regulation of cell-substrate adhesion | 2.069340e-4 |
GO:0097116 | gephyrin clustering | 2.078747e-4 |
GO:0016337 | cell-cell adhesion | 2.210613e-4 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 2.214109e-4 |
GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development | 2.243123e-4 |
GO:0060356 | leucine import | 2.263700e-4 |
GO:0002883 | regulation of hypersensitivity | 2.268779e-4 |
GO:0031640 | killing of cells of other organism | 2.288781e-4 |
GO:0060070 | canonical Wnt receptor signaling pathway | 2.312047e-4 |
GO:0010763 | positive regulation of fibroblast migration | 2.345698e-4 |
GO:0044062 | regulation of excretion | 2.347492e-4 |
GO:0048241 | epinephrine transport | 2.380757e-4 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.425761e-4 |
GO:0009119 | ribonucleoside metabolic process | 2.461642e-4 |
GO:0006754 | ATP biosynthetic process | 2.540382e-4 |
GO:0048752 | semicircular canal morphogenesis | 2.560573e-4 |
GO:0015696 | ammonium transport | 2.578002e-4 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 2.578002e-4 |
GO:0032462 | regulation of protein homooligomerization | 2.588139e-4 |
GO:0007268 | synaptic transmission | 2.589519e-4 |
GO:0009154 | purine ribonucleotide catabolic process | 2.611503e-4 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 2.614160e-4 |
GO:0060973 | cell migration involved in heart development | 2.614160e-4 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 2.614160e-4 |
GO:0060117 | auditory receptor cell development | 2.676119e-4 |
GO:0003231 | cardiac ventricle development | 2.698435e-4 |
GO:0032925 | regulation of activin receptor signaling pathway | 2.702425e-4 |
GO:0010934 | macrophage cytokine production | 2.773325e-4 |
GO:0045040 | protein import into mitochondrial outer membrane | 2.788949e-4 |
GO:0019370 | leukotriene biosynthetic process | 2.793352e-4 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 2.801454e-4 |
GO:0009261 | ribonucleotide catabolic process | 2.885323e-4 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 2.900999e-4 |
GO:0034369 | plasma lipoprotein particle remodeling | 2.957156e-4 |
GO:0045806 | negative regulation of endocytosis | 2.968153e-4 |
GO:0002579 | positive regulation of antigen processing and presentation | 2.968942e-4 |
GO:0021636 | trigeminal nerve morphogenesis | 2.990891e-4 |
GO:0003308 | negative regulation of Wnt receptor signaling pathway involved in heart development | 3.042886e-4 |
GO:0065008 | regulation of biological quality | 3.067473e-4 |
GO:0018200 | peptidyl-glutamic acid modification | 3.080538e-4 |
GO:0097104 | postsynaptic membrane assembly | 3.150104e-4 |
GO:0097119 | postsynaptic density protein 95 clustering | 3.150104e-4 |
GO:0006691 | leukotriene metabolic process | 3.172592e-4 |
GO:0003205 | cardiac chamber development | 3.218524e-4 |
GO:0006693 | prostaglandin metabolic process | 3.232397e-4 |
GO:0051128 | regulation of cellular component organization | 3.237909e-4 |
GO:0001878 | response to yeast | 3.369943e-4 |
GO:0042542 | response to hydrogen peroxide | 3.384211e-4 |
GO:0042221 | response to chemical stimulus | 3.409344e-4 |
GO:0033077 | T cell differentiation in thymus | 3.414644e-4 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 3.444221e-4 |
GO:0046333 | octopamine metabolic process | 3.513488e-4 |
GO:0042309 | homoiothermy | 3.513488e-4 |
GO:0034612 | response to tumor necrosis factor | 3.530896e-4 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 3.532821e-4 |
GO:0021773 | striatal medium spiny neuron differentiation | 3.568160e-4 |
GO:0043586 | tongue development | 3.599001e-4 |
GO:0019228 | regulation of action potential in neuron | 3.619612e-4 |
GO:0043583 | ear development | 3.642560e-4 |
GO:0070213 | protein auto-ADP-ribosylation | 3.672686e-4 |
GO:0006911 | phagocytosis, engulfment | 3.801196e-4 |
GO:0015669 | gas transport | 3.815442e-4 |
GO:0006936 | muscle contraction | 4.019634e-4 |
GO:0048708 | astrocyte differentiation | 4.020408e-4 |
GO:0048711 | positive regulation of astrocyte differentiation | 4.090180e-4 |
GO:0034614 | cellular response to reactive oxygen species | 4.101497e-4 |
GO:0043534 | blood vessel endothelial cell migration | 4.121401e-4 |
GO:0008542 | visual learning | 4.121401e-4 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 4.155106e-4 |
GO:0032497 | detection of lipopolysaccharide | 4.194813e-4 |
GO:0050921 | positive regulation of chemotaxis | 4.330416e-4 |
GO:0060446 | branching involved in open tracheal system development | 4.363873e-4 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 4.363873e-4 |
GO:0060461 | right lung morphogenesis | 4.363873e-4 |
GO:0090131 | mesenchyme migration | 4.363873e-4 |
GO:0048371 | lateral mesodermal cell differentiation | 4.363873e-4 |
GO:0010107 | potassium ion import | 4.363873e-4 |
GO:0014822 | detection of wounding | 4.363873e-4 |
GO:0009416 | response to light stimulus | 4.455169e-4 |
GO:0002077 | acrosome matrix dispersal | 4.465073e-4 |
GO:0021523 | somatic motor neuron differentiation | 4.481468e-4 |
GO:0046128 | purine ribonucleoside metabolic process | 4.552221e-4 |
GO:0035082 | axoneme assembly | 4.627239e-4 |
GO:0072208 | metanephric smooth muscle tissue development | 4.782883e-4 |
GO:0072184 | renal vesicle progenitor cell differentiation | 4.782883e-4 |
GO:0072259 | metanephric interstitial cell development | 4.782883e-4 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 4.782883e-4 |
GO:0072169 | specification of posterior mesonephric tubule identity | 4.782883e-4 |
GO:0008065 | establishment of blood-nerve barrier | 4.782883e-4 |
GO:0072168 | specification of anterior mesonephric tubule identity | 4.782883e-4 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 4.794245e-4 |
GO:0010596 | negative regulation of endothelial cell migration | 4.808742e-4 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 4.914128e-4 |
GO:0034063 | stress granule assembly | 4.991437e-4 |
GO:0015671 | oxygen transport | 4.991437e-4 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 4.996905e-4 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 4.996905e-4 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 4.996905e-4 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 4.996905e-4 |
GO:0008637 | apoptotic mitochondrial changes | 5.114397e-4 |
GO:0048368 | lateral mesoderm development | 5.126177e-4 |
GO:0032891 | negative regulation of organic acid transport | 5.195069e-4 |
GO:0051893 | regulation of focal adhesion assembly | 5.214285e-4 |
GO:0015884 | folic acid transport | 5.269902e-4 |
GO:0010595 | positive regulation of endothelial cell migration | 5.283774e-4 |
GO:0007010 | cytoskeleton organization | 5.289675e-4 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 5.320344e-4 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 5.371192e-4 |
GO:0070327 | thyroid hormone transport | 5.405263e-4 |
GO:0001779 | natural killer cell differentiation | 5.458511e-4 |
GO:0050829 | defense response to Gram-negative bacterium | 5.477077e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 5.511714e-4 |
GO:0032571 | response to vitamin K | 5.543433e-4 |
GO:0071593 | lymphocyte aggregation | 5.547449e-4 |
GO:0035457 | cellular response to interferon-alpha | 5.652045e-4 |
GO:0008366 | axon ensheathment | 5.698034e-4 |
GO:0048210 | Golgi vesicle fusion to target membrane | 5.815933e-4 |
GO:0045355 | negative regulation of interferon-alpha biosynthetic process | 5.815933e-4 |
GO:0001516 | prostaglandin biosynthetic process | 5.818348e-4 |
GO:0070212 | protein poly-ADP-ribosylation | 5.972727e-4 |
GO:0050877 | neurological system process | 6.025205e-4 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 6.049131e-4 |
GO:0072337 | modified amino acid transport | 6.129722e-4 |
GO:0009152 | purine ribonucleotide biosynthetic process | 6.131935e-4 |
GO:0051181 | cofactor transport | 6.157349e-4 |
GO:0045608 | negative regulation of auditory receptor cell differentiation | 6.191952e-4 |
GO:0090232 | positive regulation of spindle checkpoint | 6.308825e-4 |
GO:0003307 | regulation of Wnt receptor signaling pathway involved in heart development | 6.378597e-4 |
GO:0003179 | heart valve morphogenesis | 6.394867e-4 |
GO:0006725 | cellular aromatic compound metabolic process | 6.406534e-4 |
GO:0071529 | cementum mineralization | 6.532774e-4 |
GO:0006816 | calcium ion transport | 6.539807e-4 |
GO:0030048 | actin filament-based movement | 6.683629e-4 |
GO:0008285 | negative regulation of cell proliferation | 6.690498e-4 |
GO:0008360 | regulation of cell shape | 6.756682e-4 |
GO:0019049 | evasion of host defenses by virus | 6.861604e-4 |
GO:0051496 | positive regulation of stress fiber assembly | 6.887498e-4 |
GO:0010888 | negative regulation of lipid storage | 6.909821e-4 |
GO:0071675 | regulation of mononuclear cell migration | 6.961793e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 6.983648e-4 |
GO:0006200 | ATP catabolic process | 7.107512e-4 |
GO:0006884 | cell volume homeostasis | 7.271238e-4 |
GO:0014002 | astrocyte development | 7.278896e-4 |
GO:0050920 | regulation of chemotaxis | 7.293175e-4 |
GO:0001933 | negative regulation of protein phosphorylation | 7.385642e-4 |
GO:0048872 | homeostasis of number of cells | 7.463473e-4 |
GO:0003334 | keratinocyte development | 7.485889e-4 |
GO:0006695 | cholesterol biosynthetic process | 7.568365e-4 |
GO:0050896 | response to stimulus | 7.594221e-4 |
GO:0045930 | negative regulation of mitotic cell cycle | 7.628144e-4 |
GO:0051896 | regulation of protein kinase B signaling cascade | 7.753080e-4 |
GO:0060251 | regulation of glial cell proliferation | 7.763651e-4 |
GO:0042116 | macrophage activation | 7.769187e-4 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 7.990308e-4 |
GO:0032383 | regulation of intracellular cholesterol transport | 7.990308e-4 |
GO:0006836 | neurotransmitter transport | 8.030851e-4 |
GO:0060426 | lung vasculature development | 8.034414e-4 |
GO:0035813 | regulation of renal sodium excretion | 8.127483e-4 |
GO:0043313 | regulation of neutrophil degranulation | 8.190317e-4 |
GO:0048857 | neural nucleus development | 8.194800e-4 |
GO:0045217 | cell-cell junction maintenance | 8.197242e-4 |
GO:0030299 | intestinal cholesterol absorption | 8.495546e-4 |
GO:0042558 | pteridine-containing compound metabolic process | 8.521822e-4 |
GO:0043900 | regulation of multi-organism process | 8.568749e-4 |
GO:0003157 | endocardium development | 8.822788e-4 |
GO:0071482 | cellular response to light stimulus | 8.847941e-4 |
GO:0007512 | adult heart development | 9.054029e-4 |
GO:0045620 | negative regulation of lymphocyte differentiation | 9.074549e-4 |
GO:0055099 | response to high density lipoprotein particle stimulus | 9.461526e-4 |
GO:0010543 | regulation of platelet activation | 9.648830e-4 |
GO:0048545 | response to steroid hormone stimulus | 9.682112e-4 |
GO:0032459 | regulation of protein oligomerization | 9.759398e-4 |
GO:0030432 | peristalsis | 9.787932e-4 |
GO:2000667 | positive regulation of interleukin-13 secretion | 1.030955e-3 |
GO:2000703 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | 1.030955e-3 |
GO:2000734 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | 1.030955e-3 |
GO:2000665 | regulation of interleukin-13 secretion | 1.030955e-3 |
GO:0040040 | thermosensory behavior | 1.030955e-3 |
GO:2000664 | positive regulation of interleukin-5 secretion | 1.030955e-3 |
GO:2000607 | negative regulation of cell proliferation involved in mesonephros development | 1.030955e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0045940 | positive regulation of steroid metabolic process | 1.288429e-15 |
GO:0019218 | regulation of steroid metabolic process | 1.540320e-15 |
GO:0033700 | phospholipid efflux | 8.335341e-13 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.107385e-11 |
GO:0060192 | negative regulation of lipase activity | 2.150423e-11 |
GO:0030301 | cholesterol transport | 3.786042e-11 |
GO:0046890 | regulation of lipid biosynthetic process | 4.264106e-11 |
GO:0034382 | chylomicron remnant clearance | 1.291169e-10 |
GO:0010872 | regulation of cholesterol esterification | 1.564439e-10 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.642276e-10 |
GO:0033344 | cholesterol efflux | 6.939116e-10 |
GO:0010873 | positive regulation of cholesterol esterification | 7.215566e-10 |
GO:0042304 | regulation of fatty acid biosynthetic process | 8.042770e-10 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.559570e-9 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.653868e-9 |
GO:0032374 | regulation of cholesterol transport | 1.800046e-9 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.994234e-9 |
GO:0032352 | positive regulation of hormone metabolic process | 3.990110e-9 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 4.296273e-9 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 4.383551e-9 |
GO:0050810 | regulation of steroid biosynthetic process | 1.049043e-8 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.321098e-8 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.657300e-8 |
GO:0071827 | plasma lipoprotein particle organization | 3.790273e-8 |
GO:0048739 | cardiac muscle fiber development | 5.595884e-8 |
GO:0016074 | snoRNA metabolic process | 5.890449e-8 |
GO:0032350 | regulation of hormone metabolic process | 6.763974e-8 |
GO:0010893 | positive regulation of steroid biosynthetic process | 7.482825e-8 |
GO:0032375 | negative regulation of cholesterol transport | 9.407317e-8 |
GO:0006641 | triglyceride metabolic process | 1.002624e-7 |
GO:0033490 | cholesterol biosynthetic process via lathosterol | 1.630442e-7 |
GO:0046885 | regulation of hormone biosynthetic process | 2.308109e-7 |
GO:0060191 | regulation of lipase activity | 2.667164e-7 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 2.848020e-7 |
GO:0002227 | innate immune response in mucosa | 3.317290e-7 |
GO:0051004 | regulation of lipoprotein lipase activity | 3.867892e-7 |
GO:0046464 | acylglycerol catabolic process | 3.935455e-7 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 3.938864e-7 |
GO:0019433 | triglyceride catabolic process | 3.986751e-7 |
GO:0046886 | positive regulation of hormone biosynthetic process | 4.473443e-7 |
GO:0060696 | regulation of phospholipid catabolic process | 4.838520e-7 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 5.084655e-7 |
GO:0002456 | T cell mediated immunity | 6.270316e-7 |
GO:0034447 | very-low-density lipoprotein particle clearance | 6.816690e-7 |
GO:0046889 | positive regulation of lipid biosynthetic process | 1.118041e-6 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 1.245582e-6 |
GO:0050995 | negative regulation of lipid catabolic process | 1.497797e-6 |
GO:0050927 | positive regulation of positive chemotaxis | 1.606276e-6 |
GO:0006982 | response to lipid hydroperoxide | 1.692026e-6 |
GO:0046503 | glycerolipid catabolic process | 1.780222e-6 |
GO:0070328 | triglyceride homeostasis | 1.917737e-6 |
GO:0030300 | regulation of intestinal cholesterol absorption | 2.060157e-6 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 2.066787e-6 |
GO:0043503 | skeletal muscle fiber adaptation | 2.361643e-6 |
GO:0008203 | cholesterol metabolic process | 2.463319e-6 |
GO:0002449 | lymphocyte mediated immunity | 2.602813e-6 |
GO:0019216 | regulation of lipid metabolic process | 2.644318e-6 |
GO:0060037 | pharyngeal system development | 2.840516e-6 |
GO:0055090 | acylglycerol homeostasis | 3.005374e-6 |
GO:0090181 | regulation of cholesterol metabolic process | 3.180198e-6 |
GO:0045922 | negative regulation of fatty acid metabolic process | 3.321554e-6 |
GO:0045834 | positive regulation of lipid metabolic process | 3.553457e-6 |
GO:0050921 | positive regulation of chemotaxis | 3.641427e-6 |
GO:0006639 | acylglycerol metabolic process | 3.970595e-6 |
GO:0033238 | regulation of cellular amine metabolic process | 4.842982e-6 |
GO:0050930 | induction of positive chemotaxis | 5.386434e-6 |
GO:0006638 | neutral lipid metabolic process | 6.380989e-6 |
GO:0050926 | regulation of positive chemotaxis | 6.900758e-6 |
GO:0044058 | regulation of digestive system process | 7.072659e-6 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 7.073418e-6 |
GO:0006869 | lipid transport | 8.026591e-6 |
GO:0008207 | C21-steroid hormone metabolic process | 8.910233e-6 |
GO:0010876 | lipid localization | 1.052097e-5 |
GO:0048520 | positive regulation of behavior | 1.217779e-5 |
GO:0051129 | negative regulation of cellular component organization | 1.434747e-5 |
GO:0043691 | reverse cholesterol transport | 1.525745e-5 |
GO:0060415 | muscle tissue morphogenesis | 1.622071e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.626971e-5 |
GO:0072376 | protein activation cascade | 1.637822e-5 |
GO:0016079 | synaptic vesicle exocytosis | 1.642391e-5 |
GO:0016125 | sterol metabolic process | 1.925989e-5 |
GO:0060290 | transdifferentiation | 2.057703e-5 |
GO:0002443 | leukocyte mediated immunity | 2.242044e-5 |
GO:0002921 | negative regulation of humoral immune response | 2.282112e-5 |
GO:0000305 | response to oxygen radical | 2.439285e-5 |
GO:0045065 | cytotoxic T cell differentiation | 2.454185e-5 |
GO:0006956 | complement activation | 2.624819e-5 |
GO:0048747 | muscle fiber development | 2.691908e-5 |
GO:0045540 | regulation of cholesterol biosynthetic process | 2.786667e-5 |
GO:0032369 | negative regulation of lipid transport | 3.109990e-5 |
GO:0007218 | neuropeptide signaling pathway | 3.206214e-5 |
GO:0050994 | regulation of lipid catabolic process | 3.208114e-5 |
GO:0003012 | muscle system process | 3.680187e-5 |
GO:0060620 | regulation of cholesterol import | 3.696092e-5 |
GO:0032693 | negative regulation of interleukin-10 production | 4.069308e-5 |
GO:0010896 | regulation of triglyceride catabolic process | 4.253069e-5 |
GO:0001867 | complement activation, lectin pathway | 4.337247e-5 |
GO:0045577 | regulation of B cell differentiation | 4.930709e-5 |
GO:0002358 | B cell homeostatic proliferation | 5.035404e-5 |
GO:0001845 | phagolysosome assembly | 5.035404e-5 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 5.085895e-5 |
GO:0006936 | muscle contraction | 5.182466e-5 |
GO:0010625 | positive regulation of Schwann cell proliferation | 5.429870e-5 |
GO:0060621 | negative regulation of cholesterol import | 5.554487e-5 |
GO:0000303 | response to superoxide | 5.557016e-5 |
GO:0019240 | citrulline biosynthetic process | 5.870005e-5 |
GO:0044342 | type B pancreatic cell proliferation | 5.936938e-5 |
GO:0018101 | peptidyl-citrulline biosynthetic process from peptidyl-arginine | 5.936938e-5 |
GO:0002635 | negative regulation of germinal center formation | 5.936938e-5 |
GO:0031034 | myosin filament assembly | 5.979638e-5 |
GO:0051615 | histamine uptake | 6.047047e-5 |
GO:0006642 | triglyceride mobilization | 6.369591e-5 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 6.414908e-5 |
GO:0060537 | muscle tissue development | 7.311725e-5 |
GO:0002830 | positive regulation of type 2 immune response | 7.545503e-5 |
GO:0035640 | exploration behavior | 8.374319e-5 |
GO:0006662 | glycerol ether metabolic process | 8.674701e-5 |
GO:0003229 | ventricular cardiac muscle tissue development | 9.108193e-5 |
GO:0042492 | gamma-delta T cell differentiation | 9.487274e-5 |
GO:0003208 | cardiac ventricle morphogenesis | 9.527296e-5 |
GO:0044062 | regulation of excretion | 9.603164e-5 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 1.065995e-4 |
GO:0042632 | cholesterol homeostasis | 1.077384e-4 |
GO:0051494 | negative regulation of cytoskeleton organization | 1.087162e-4 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 1.089685e-4 |
GO:0006700 | C21-steroid hormone biosynthetic process | 1.090232e-4 |
GO:0050819 | negative regulation of coagulation | 1.171417e-4 |
GO:0032368 | regulation of lipid transport | 1.187404e-4 |
GO:0090102 | cochlea development | 1.191375e-4 |
GO:0010454 | negative regulation of cell fate commitment | 1.231141e-4 |
GO:0009582 | detection of abiotic stimulus | 1.233714e-4 |
GO:0017004 | cytochrome complex assembly | 1.260128e-4 |
GO:0007517 | muscle organ development | 1.261116e-4 |
GO:0032094 | response to food | 1.345103e-4 |
GO:0060754 | positive regulation of mast cell chemotaxis | 1.348549e-4 |
GO:0046600 | negative regulation of centriole replication | 1.355099e-4 |
GO:0007269 | neurotransmitter secretion | 1.411391e-4 |
GO:0002707 | negative regulation of lymphocyte mediated immunity | 1.468427e-4 |
GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 1.531335e-4 |
GO:0018364 | peptidyl-glutamine methylation | 1.531335e-4 |
GO:0008633 | activation of pro-apoptotic gene products | 1.542384e-4 |
GO:0071169 | establishment of protein localization to chromatin | 1.562717e-4 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 1.565050e-4 |
GO:0005997 | xylulose metabolic process | 1.602607e-4 |
GO:0019430 | removal of superoxide radicals | 1.721713e-4 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 1.787774e-4 |
GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.813187e-4 |
GO:0034381 | plasma lipoprotein particle clearance | 1.895260e-4 |
GO:0032231 | regulation of actin filament bundle assembly | 2.033986e-4 |
GO:0042732 | D-xylose metabolic process | 2.110323e-4 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.125011e-4 |
GO:0000387 | spliceosomal snRNP assembly | 2.238300e-4 |
GO:0060193 | positive regulation of lipase activity | 2.269853e-4 |
GO:0050746 | regulation of lipoprotein metabolic process | 2.326522e-4 |
GO:0032103 | positive regulation of response to external stimulus | 2.515230e-4 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 2.537528e-4 |
GO:0045906 | negative regulation of vasoconstriction | 2.695829e-4 |
GO:0045806 | negative regulation of endocytosis | 2.728934e-4 |
GO:0061061 | muscle structure development | 2.745088e-4 |
GO:0003205 | cardiac chamber development | 2.762933e-4 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 2.763890e-4 |
GO:0003231 | cardiac ventricle development | 2.800590e-4 |
GO:0014706 | striated muscle tissue development | 2.813899e-4 |
GO:0031100 | organ regeneration | 2.855593e-4 |
GO:0033979 | box H/ACA snoRNA metabolic process | 2.999249e-4 |
GO:0046086 | adenosine biosynthetic process | 2.999249e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 2.999249e-4 |
GO:0006196 | AMP catabolic process | 2.999249e-4 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 3.022061e-4 |
GO:0007522 | visceral muscle development | 3.056240e-4 |
GO:0061041 | regulation of wound healing | 3.179545e-4 |
GO:0030878 | thyroid gland development | 3.234349e-4 |
GO:0030029 | actin filament-based process | 3.239792e-4 |
GO:0045823 | positive regulation of heart contraction | 3.448744e-4 |
GO:0034374 | low-density lipoprotein particle remodeling | 3.610703e-4 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 3.821671e-4 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 3.821671e-4 |
GO:0018904 | organic ether metabolic process | 3.994927e-4 |
GO:0007010 | cytoskeleton organization | 4.073149e-4 |
GO:0008211 | glucocorticoid metabolic process | 4.134689e-4 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 4.247503e-4 |
GO:0002897 | positive regulation of central B cell tolerance induction | 4.247503e-4 |
GO:0002508 | central tolerance induction | 4.247503e-4 |
GO:0000238 | zygotene | 4.247503e-4 |
GO:0090183 | regulation of kidney development | 4.349980e-4 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 4.417671e-4 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 4.428985e-4 |
GO:0002902 | regulation of B cell apoptosis | 4.438161e-4 |
GO:0007183 | SMAD protein complex assembly | 4.459320e-4 |
GO:0006887 | exocytosis | 4.509764e-4 |
GO:0043279 | response to alkaloid | 4.576840e-4 |
GO:0007202 | activation of phospholipase C activity | 4.708384e-4 |
GO:0045343 | regulation of MHC class I biosynthetic process | 4.719019e-4 |
GO:0065008 | regulation of biological quality | 4.761751e-4 |
GO:0042454 | ribonucleoside catabolic process | 4.835093e-4 |
GO:0045579 | positive regulation of B cell differentiation | 4.848018e-4 |
GO:0002250 | adaptive immune response | 4.864232e-4 |
GO:0008202 | steroid metabolic process | 5.104239e-4 |
GO:0061290 | canonical Wnt receptor signaling pathway involved in metanephric kidney development | 5.235191e-4 |
GO:0046599 | regulation of centriole replication | 5.235191e-4 |
GO:0030195 | negative regulation of blood coagulation | 5.387468e-4 |
GO:0045217 | cell-cell junction maintenance | 5.390648e-4 |
GO:0043583 | ear development | 5.432377e-4 |
GO:0042730 | fibrinolysis | 5.464910e-4 |
GO:0046604 | positive regulation of mitotic centrosome separation | 5.465623e-4 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 5.530068e-4 |
GO:0048644 | muscle organ morphogenesis | 5.638317e-4 |
GO:0048878 | chemical homeostasis | 5.678282e-4 |
GO:0055008 | cardiac muscle tissue morphogenesis | 5.802887e-4 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 5.972229e-4 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 6.099404e-4 |
GO:0051346 | negative regulation of hydrolase activity | 6.174792e-4 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 6.438527e-4 |
GO:2000611 | positive regulation of thyroid hormone generation | 6.501459e-4 |
GO:0006066 | alcohol metabolic process | 6.558890e-4 |
GO:0046434 | organophosphate catabolic process | 6.596036e-4 |
GO:0070869 | heterochromatin formation involved in chromatin silencing | 6.631349e-4 |
GO:0070327 | thyroid hormone transport | 6.705445e-4 |
GO:0030049 | muscle filament sliding | 6.925847e-4 |
GO:0030035 | microspike assembly | 6.988235e-4 |
GO:0001935 | endothelial cell proliferation | 7.102562e-4 |
GO:0046874 | quinolinate metabolic process | 7.377651e-4 |
GO:0002088 | lens development in camera-type eye | 7.438040e-4 |
GO:0071956 | cellular component maintenance at cellular level | 7.478199e-4 |
GO:0003350 | pulmonary myocardium development | 7.607359e-4 |
GO:0051204 | protein insertion into mitochondrial membrane | 7.776997e-4 |
GO:0060070 | canonical Wnt receptor signaling pathway | 7.779741e-4 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 8.016397e-4 |
GO:0060026 | convergent extension | 8.034978e-4 |
GO:0009887 | organ morphogenesis | 8.184559e-4 |
GO:0006958 | complement activation, classical pathway | 8.205664e-4 |
GO:0045647 | negative regulation of erythrocyte differentiation | 8.409688e-4 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 8.409688e-4 |
GO:0003206 | cardiac chamber morphogenesis | 8.457571e-4 |
GO:0009115 | xanthine catabolic process | 8.513485e-4 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 8.521191e-4 |
GO:0015671 | oxygen transport | 8.521191e-4 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 8.521191e-4 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 8.923209e-4 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 9.374145e-4 |
GO:0060299 | negative regulation of sarcomere organization | 9.374145e-4 |
GO:0006258 | UDP-glucose catabolic process | 9.374145e-4 |
GO:0010455 | positive regulation of cell fate commitment | 9.374145e-4 |
GO:0034442 | regulation of lipoprotein oxidation | 9.439339e-4 |
GO:0045608 | negative regulation of auditory receptor cell differentiation | 9.603089e-4 |
GO:0010897 | negative regulation of triglyceride catabolic process | 9.603089e-4 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 9.603089e-4 |
GO:0045576 | mast cell activation | 9.638155e-4 |
GO:0032101 | regulation of response to external stimulus | 9.727403e-4 |
GO:0070627 | ferrous iron import | 1.007200e-3 |
GO:0090177 | establishment of planar polarity involved in neural tube closure | 1.007200e-3 |
GO:0008057 | eye pigment granule organization | 1.007200e-3 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 1.007200e-3 |
GO:0015692 | lead ion transport | 1.007200e-3 |
GO:0015676 | vanadium ion transport | 1.007200e-3 |
GO:0032233 | positive regulation of actin filament bundle assembly | 1.025023e-3 |
GO:0009581 | detection of external stimulus | 1.031980e-3 |
GO:0070306 | lens fiber cell differentiation | 1.036066e-3 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 1.055596e-3 |
GO:0060020 | Bergmann glial cell differentiation | 1.058161e-3 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 1.059278e-3 |
GO:0035304 | regulation of protein dephosphorylation | 1.093259e-3 |
GO:0002086 | diaphragm contraction | 1.103792e-3 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 1.103792e-3 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 1.126249e-3 |
GO:0009996 | negative regulation of cell fate specification | 1.126249e-3 |
GO:0042267 | natural killer cell mediated cytotoxicity | 1.129952e-3 |
GO:0048731 | system development | 1.136536e-3 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 1.151317e-3 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 1.155529e-3 |
GO:0022417 | protein maturation by protein folding | 1.155529e-3 |
GO:0051239 | regulation of multicellular organismal process | 1.188391e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 1.199695e-3 |
GO:0006959 | humoral immune response | 1.210036e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 1.215650e-3 |
GO:0007423 | sensory organ development | 1.217656e-3 |
GO:0033025 | regulation of mast cell apoptosis | 1.244822e-3 |
GO:0006917 | induction of apoptosis | 1.245005e-3 |
GO:0046110 | xanthine metabolic process | 1.247395e-3 |
GO:0032717 | negative regulation of interleukin-8 production | 1.247395e-3 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 1.249242e-3 |
GO:0006438 | valyl-tRNA aminoacylation | 1.249242e-3 |
GO:0010863 | positive regulation of phospholipase C activity | 1.262675e-3 |
GO:0043502 | regulation of muscle adaptation | 1.277657e-3 |
GO:0051492 | regulation of stress fiber assembly | 1.278170e-3 |
GO:0070670 | response to interleukin-4 | 1.287026e-3 |
GO:0051905 | establishment of pigment granule localization | 1.303277e-3 |
GO:0060251 | regulation of glial cell proliferation | 1.307971e-3 |
GO:0048729 | tissue morphogenesis | 1.323426e-3 |
GO:0002820 | negative regulation of adaptive immune response | 1.325699e-3 |
GO:0060749 | mammary gland alveolus development | 1.347637e-3 |
GO:0071702 | organic substance transport | 1.379783e-3 |
GO:0012502 | induction of programmed cell death | 1.405109e-3 |
GO:0048563 | post-embryonic organ morphogenesis | 1.425945e-3 |
GO:0002385 | mucosal immune response | 1.425945e-3 |
GO:0008105 | asymmetric protein localization | 1.430786e-3 |
GO:0009164 | nucleoside catabolic process | 1.457437e-3 |
GO:0007621 | negative regulation of female receptivity | 1.496409e-3 |
GO:0045607 | regulation of auditory receptor cell differentiation | 1.496409e-3 |
GO:0000052 | citrulline metabolic process | 1.496409e-3 |
GO:0055088 | lipid homeostasis | 1.499252e-3 |
GO:0032736 | positive regulation of interleukin-13 production | 1.499526e-3 |
GO:0030263 | apoptotic chromosome condensation | 1.501800e-3 |
GO:0002352 | B cell negative selection | 1.501800e-3 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 1.501800e-3 |
GO:0003016 | respiratory system process | 1.515882e-3 |
GO:0045930 | negative regulation of mitotic cell cycle | 1.535246e-3 |
GO:0051919 | positive regulation of fibrinolysis | 1.550858e-3 |
GO:0070366 | regulation of hepatocyte differentiation | 1.550858e-3 |
GO:0006705 | mineralocorticoid biosynthetic process | 1.552665e-3 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.566993e-3 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 1.572278e-3 |
GO:0032026 | response to magnesium ion | 1.575749e-3 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.625024e-3 |
GO:0061009 | common bile duct development | 1.633689e-3 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 1.633689e-3 |
GO:0030036 | actin cytoskeleton organization | 1.634364e-3 |
GO:0042537 | benzene-containing compound metabolic process | 1.668293e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 1.685893e-3 |
GO:0008637 | apoptotic mitochondrial changes | 1.748000e-3 |
GO:0016998 | cell wall macromolecule catabolic process | 1.751062e-3 |
GO:0090086 | negative regulation of protein deubiquitination | 1.791948e-3 |
GO:0071674 | mononuclear cell migration | 1.791948e-3 |
GO:0003094 | glomerular filtration | 1.791948e-3 |
GO:0042946 | glucoside transport | 1.791948e-3 |
GO:0032571 | response to vitamin K | 1.799153e-3 |
GO:0034375 | high-density lipoprotein particle remodeling | 1.800520e-3 |
GO:0019852 | L-ascorbic acid metabolic process | 1.843301e-3 |
GO:0006584 | catecholamine metabolic process | 1.862864e-3 |
GO:0016576 | histone dephosphorylation | 1.869232e-3 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 1.908289e-3 |
GO:0048239 | negative regulation of DNA recombination at telomere | 1.911568e-3 |
GO:0042450 | arginine biosynthetic process via ornithine | 1.911568e-3 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.911568e-3 |
GO:0019676 | ammonia assimilation cycle | 1.911568e-3 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 1.911568e-3 |
GO:0048690 | regulation of axon extension involved in regeneration | 1.928595e-3 |
GO:0035552 | oxidative single-stranded DNA demethylation | 1.928595e-3 |
GO:0051297 | centrosome organization | 2.007888e-3 |
GO:0042220 | response to cocaine | 2.007888e-3 |
GO:0050982 | detection of mechanical stimulus | 2.019642e-3 |
GO:0048839 | inner ear development | 2.081364e-3 |
GO:0015734 | taurine transport | 2.116001e-3 |
GO:0002904 | positive regulation of B cell apoptosis | 2.126174e-3 |
GO:0006811 | ion transport | 2.128574e-3 |
GO:0050847 | progesterone receptor signaling pathway | 2.133728e-3 |
GO:0035235 | ionotropic glutamate receptor signaling pathway | 2.150502e-3 |
GO:0003007 | heart morphogenesis | 2.172291e-3 |
GO:0070383 | DNA cytosine deamination | 2.211896e-3 |
GO:0043985 | histone H4-R3 methylation | 2.211896e-3 |
GO:0010529 | negative regulation of transposition | 2.211896e-3 |
GO:0010977 | negative regulation of neuron projection development | 2.232189e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 2.235533e-3 |
GO:0003008 | system process | 2.236130e-3 |
GO:0060029 | convergent extension involved in organogenesis | 2.240399e-3 |
GO:0016575 | histone deacetylation | 2.264588e-3 |
GO:2000172 | regulation of branching morphogenesis of a nerve | 2.336904e-3 |
GO:0060359 | response to ammonium ion | 2.336904e-3 |
GO:0010624 | regulation of Schwann cell proliferation | 2.336904e-3 |
GO:0050920 | regulation of chemotaxis | 2.347832e-3 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 2.398775e-3 |
GO:0044242 | cellular lipid catabolic process | 2.424707e-3 |
GO:0016477 | cell migration | 2.429565e-3 |
GO:0033131 | regulation of glucokinase activity | 2.434973e-3 |
GO:0034421 | post-translational protein acetylation | 2.461518e-3 |
GO:0021915 | neural tube development | 2.463680e-3 |
GO:0032656 | regulation of interleukin-13 production | 2.478163e-3 |
GO:0051608 | histamine transport | 2.534382e-3 |
GO:0001707 | mesoderm formation | 2.564305e-3 |
GO:0015914 | phospholipid transport | 2.583702e-3 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 2.628403e-3 |
GO:0071287 | cellular response to manganese ion | 2.628403e-3 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 2.630705e-3 |
GO:0018958 | phenol-containing compound metabolic process | 2.642602e-3 |
GO:0019722 | calcium-mediated signaling | 2.712146e-3 |
GO:0006145 | purine base catabolic process | 2.739812e-3 |
GO:0002687 | positive regulation of leukocyte migration | 2.767659e-3 |
GO:0001777 | T cell homeostatic proliferation | 2.799780e-3 |
GO:0034770 | histone H4-K20 methylation | 2.832402e-3 |
GO:0048513 | organ development | 2.861433e-3 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 2.884726e-3 |
GO:0043181 | vacuolar sequestering | 2.888306e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 2.888306e-3 |
GO:0001811 | negative regulation of type I hypersensitivity | 2.888306e-3 |
GO:0002638 | negative regulation of immunoglobulin production | 2.888306e-3 |
GO:0051917 | regulation of fibrinolysis | 2.950692e-3 |
GO:0061037 | negative regulation of cartilage development | 2.970826e-3 |
GO:0048016 | inositol phosphate-mediated signaling | 2.979953e-3 |
GO:2000227 | negative regulation of pancreatic A cell differentiation | 2.983908e-3 |
GO:2000978 | negative regulation of forebrain neuron differentiation | 2.983908e-3 |
GO:0061106 | negative regulation of stomach neuroendocrine cell differentiation | 2.983908e-3 |
GO:0046331 | lateral inhibition | 2.983908e-3 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 2.983908e-3 |
GO:0050918 | positive chemotaxis | 2.992418e-3 |
GO:0002688 | regulation of leukocyte chemotaxis | 2.996597e-3 |
GO:0061002 | negative regulation of dendritic spine morphogenesis | 3.025986e-3 |
GO:0043420 | anthranilate metabolic process | 3.072476e-3 |
GO:0050861 | positive regulation of B cell receptor signaling pathway | 3.072476e-3 |
GO:0034516 | response to vitamin B6 | 3.072476e-3 |
GO:0002430 | complement receptor mediated signaling pathway | 3.072476e-3 |
GO:0043462 | regulation of ATPase activity | 3.145498e-3 |
GO:0003230 | cardiac atrium development | 3.165372e-3 |
GO:0006939 | smooth muscle contraction | 3.215021e-3 |
GO:0045619 | regulation of lymphocyte differentiation | 3.252948e-3 |
GO:0051496 | positive regulation of stress fiber assembly | 3.256527e-3 |
GO:0002251 | organ or tissue specific immune response | 3.264714e-3 |
GO:0051336 | regulation of hydrolase activity | 3.356419e-3 |
GO:0050818 | regulation of coagulation | 3.385672e-3 |
GO:0060068 | vagina development | 3.391306e-3 |
GO:0010898 | positive regulation of triglyceride catabolic process | 3.402448e-3 |
GO:0001505 | regulation of neurotransmitter levels | 3.408106e-3 |
GO:0002572 | pro-T cell differentiation | 3.428985e-3 |
GO:0050996 | positive regulation of lipid catabolic process | 3.442618e-3 |
GO:0031345 | negative regulation of cell projection organization | 3.524403e-3 |
GO:0050801 | ion homeostasis | 3.573888e-3 |
GO:0048144 | fibroblast proliferation | 3.711761e-3 |
GO:0035725 | sodium ion transmembrane transport | 3.716780e-3 |
GO:0051901 | positive regulation of mitochondrial depolarization | 3.739019e-3 |
GO:0031579 | membrane raft organization | 3.763018e-3 |
GO:0010350 | cellular response to magnesium starvation | 3.785919e-3 |
GO:0007340 | acrosome reaction | 3.795627e-3 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.827984e-3 |
GO:0035094 | response to nicotine | 3.844164e-3 |
GO:0030048 | actin filament-based movement | 3.844164e-3 |
GO:0010518 | positive regulation of phospholipase activity | 3.892285e-3 |
GO:0046847 | filopodium assembly | 3.918147e-3 |
GO:0010951 | negative regulation of endopeptidase activity | 4.024809e-3 |
GO:0071242 | cellular response to ammonium ion | 4.038928e-3 |
GO:0051918 | negative regulation of fibrinolysis | 4.045739e-3 |
GO:0050710 | negative regulation of cytokine secretion | 4.056604e-3 |
GO:0006704 | glucocorticoid biosynthetic process | 4.077509e-3 |
GO:0072182 | regulation of nephron tubule epithelial cell differentiation | 4.223896e-3 |
GO:0016055 | Wnt receptor signaling pathway | 4.260256e-3 |
GO:0046031 | ADP metabolic process | 4.283959e-3 |
GO:0007527 | adult somatic muscle development | 4.295869e-3 |
GO:0044240 | multicellular organismal lipid catabolic process | 4.318692e-3 |
GO:0043954 | cellular component maintenance | 4.419253e-3 |
GO:2000273 | positive regulation of receptor activity | 4.419253e-3 |
GO:0052548 | regulation of endopeptidase activity | 4.450670e-3 |
GO:0030509 | BMP signaling pathway | 4.523783e-3 |
GO:0001906 | cell killing | 4.556816e-3 |
GO:0042157 | lipoprotein metabolic process | 4.566867e-3 |
GO:2000043 | regulation of cardiac cell fate specification | 4.593309e-3 |
GO:0070367 | negative regulation of hepatocyte differentiation | 4.616354e-3 |
GO:0021501 | prechordal plate formation | 4.616354e-3 |
GO:0021547 | midbrain-hindbrain boundary initiation | 4.616354e-3 |
GO:0019725 | cellular homeostasis | 4.636969e-3 |
GO:0034097 | response to cytokine stimulus | 4.647271e-3 |
GO:0009132 | nucleoside diphosphate metabolic process | 4.726839e-3 |
GO:0046653 | tetrahydrofolate metabolic process | 4.728110e-3 |
GO:0045833 | negative regulation of lipid metabolic process | 4.737008e-3 |
GO:0050917 | sensory perception of umami taste | 4.741076e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 4.885381e-3 |
GO:0060480 | lung goblet cell differentiation | 4.885381e-3 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 4.886372e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 4.914465e-3 |
GO:0006760 | folic acid-containing compound metabolic process | 4.951239e-3 |
GO:0060841 | venous blood vessel development | 4.960797e-3 |
GO:0061326 | renal tubule development | 5.013260e-3 |
GO:0048489 | synaptic vesicle transport | 5.043564e-3 |
GO:0048870 | cell motility | 5.105548e-3 |
GO:0051656 | establishment of organelle localization | 5.145333e-3 |
GO:0010638 | positive regulation of organelle organization | 5.146969e-3 |
GO:0032844 | regulation of homeostatic process | 5.261497e-3 |
GO:0035814 | negative regulation of renal sodium excretion | 5.324152e-3 |
GO:0051602 | response to electrical stimulus | 5.368274e-3 |
GO:0035121 | tail morphogenesis | 5.369774e-3 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 5.387925e-3 |
GO:0035813 | regulation of renal sodium excretion | 5.390544e-3 |
GO:0043434 | response to peptide hormone stimulus | 5.505051e-3 |
GO:0060627 | regulation of vesicle-mediated transport | 5.508982e-3 |
GO:0032836 | glomerular basement membrane development | 5.511302e-3 |
GO:0071316 | cellular response to nicotine | 5.511302e-3 |
GO:0009972 | cytidine deamination | 5.511302e-3 |
GO:0002507 | tolerance induction | 5.538235e-3 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 5.582139e-3 |
GO:0043406 | positive regulation of MAP kinase activity | 5.601325e-3 |
GO:0032674 | regulation of interleukin-5 production | 5.615846e-3 |
GO:0014743 | regulation of muscle hypertrophy | 5.615846e-3 |
GO:0085029 | extracellular matrix assembly | 5.654362e-3 |
GO:0042035 | regulation of cytokine biosynthetic process | 5.702327e-3 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 5.738922e-3 |
GO:0072337 | modified amino acid transport | 5.741887e-3 |
GO:0070307 | lens fiber cell development | 5.743327e-3 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 5.767065e-3 |
GO:0002115 | store-operated calcium entry | 5.767065e-3 |
GO:0006941 | striated muscle contraction | 5.847240e-3 |
GO:0006507 | GPI anchor release | 5.852559e-3 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 5.852559e-3 |
GO:0003142 | cardiogenic plate morphogenesis | 5.852559e-3 |
GO:0001828 | inner cell mass cellular morphogenesis | 5.852559e-3 |
GO:0009435 | NAD biosynthetic process | 5.859169e-3 |
GO:0009612 | response to mechanical stimulus | 5.878115e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 5.908151e-3 |
GO:0006694 | steroid biosynthetic process | 5.942785e-3 |
GO:0060913 | cardiac cell fate determination | 5.943137e-3 |
GO:0030001 | metal ion transport | 5.960999e-3 |
GO:0032869 | cellular response to insulin stimulus | 6.032884e-3 |
GO:0032754 | positive regulation of interleukin-5 production | 6.117746e-3 |
GO:0070933 | histone H4 deacetylation | 6.145784e-3 |